DiaMedica Therapeutics announced the appointment of David Wambeke, as Chief Business Officer CBO . In this position, he will lead business development, including financing and partnering strategies, and acceleration of prioritized development programs, as well as other business operations.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DMAC:
